Asterias Biotherapeutics, Inc. Finite-Lived Intangible Assets, Net
Asterias Biotherapeutics, Inc. had Finite-Lived Intangible Assets, Net of $13.43 million as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2018-11-09
- 2018-09-30: Finite-Lived Intangible Assets, Net $13.43M.
- 2018-06-30: Finite-Lived Intangible Assets, Net $14.10M.
- 2018-03-31: Finite-Lived Intangible Assets, Net $14.77M.
- 2017-12-31: Finite-Lived Intangible Assets, Net $15.44M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2018-09-30 | $13.43M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $14.10M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $14.77M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $15.44M 10-Q · filed 2018-11-09 | |
| 2017-09-30 | $16.12M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $16.79M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $17.46M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $18.13M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $18.80M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $19.47M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $20.14M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.82M 10-K · filed 2017-03-28 | |
| 2015-09-30 | $21.49M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $22.16M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $22.83M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $23.50M 10-K · filed 2016-03-29 | $23.50M 10-K · filed 2015-03-11 |
| 2014-09-30 | $26.12M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $26.84M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $27.57M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $28.29M 10-K · filed 2015-03-11 | |
| 2013-03-31 | $28.29M 10-Q · filed 2014-05-12 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |